Patents/Inventors

Scott E. Lazerwith

San Francisco, CAUS15 patents

15 Patents

US124733142025
Phospholipid Compounds and Uses Thereof
Gilead Sciences, Inc.
0 cites
US124484002025
KRAS G12D Modulating Compounds
Gilead Sciences, Inc.
0 cites
US124101832025
Sars-cov2 Main Protease Inhibitors
Gilead Sciences, Inc.
0 cites
US122081102025
Phospholipid Compounds and Uses Thereof
Gilead Sciences, Inc.
0 cites
US121616252024
Substituted Pyrrolizine Compounds and Uses Thereof
Gilead Sciences, Inc.
0 cites
US121628442024
MCL-1 Inhibitors
Gilead Sciences, Inc.
0 cites
US120775372024
Capsid Inhibitors for the Treatment of HIV
Gilead Sciences, Inc.
0 cites
US120704552024
Thienopyrrole Compounds
Gilead Sciences, Inc.
0 cites
US120309042024
Phospholipid Compounds and Uses Thereof
Gilead Sciences, Inc.
0 cites
US119639672024
Phospholipid Compounds and Uses Thereof
Gilead Sciences, Inc.
0 cites
US117731222023
Phospholipid Compounds and Uses Thereof
Gilead Sciences. Inc.
0 cites
US116800642023
Capsid Inhibitors for the Treatment of HIV
Gilead Sciences, Inc.
0 cites
US116614312023
Thienopyrrole Compounds
Gilead Sciences, Inc.
0 cites
US116434002023
MCL-1 Inhibitors
Gilead Sciences, Inc.
0 cites
US115489012023
Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for Treating Viral Infections
Gilead Sciences, Inc.
0 cites